Table.
Sensitivity and specificity of testing for microscopic haematuria in different patient groups at high risk of bladder cancer
| Criteria for including patients
|
No (%) with bladder cancer
|
Sensitivity (%)
|
Specificity (%)
|
|---|---|---|---|
| Follow up after bladder cancer24 | 192 (41) | 41 | 87 |
| Presenting to urology clinic25 | 130 (46) | 69 | 68 |
| Undergoing cystoscopy26 | 196 (29) | 47 | 84 |